DEA cites lack of safety, abuse potential in rejection of medical marijuana

The U.S. Drug Enforcement Administration has announced several actions on marijuana classification and research, as well as hemp cultivation, the agency stated in a press release.The actions included a denial of two petitions to reschedule marijuana in the Controlled Substances Act (CSA), calling for "sound, scientific, and rigorous" research.